|
NSF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22900000002024E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.954100E-04 |
| Normal-vs-Stage2 |
7.181600E-02 |
| Normal-vs-Stage3 |
1.003600E-01 |
| Normal-vs-Stage4 |
7.443600E-01 |
| Stage1-vs-Stage2 |
9.457800E-01 |
| Stage1-vs-Stage3 |
7.268200E-01 |
| Stage1-vs-Stage4 |
3.530200E-01 |
| Stage2-vs-Stage3 |
7.376800E-01 |
| Stage2-vs-Stage4 |
3.438800E-01 |
| Stage3-vs-Stage4 |
4.785400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.80629999999971E-05 |
| Normal-vs-AfricanAmerican |
6.722200E-03 |
| Normal-vs-Asian |
1.815840E-01 |
| Caucasian-vs-AfricanAmerican |
9.105600E-01 |
| Caucasian-vs-Asian |
8.076000E-01 |
| AfricanAmerican-vs-Asian |
7.643800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.564700E-04 |
| Normal-vs-Female |
1.47230000002718E-06 |
| Male-vs-Female |
6.362800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.408970E-01 |
| Normal-vs-Extreme_Weight |
1.641780E-02 |
| Normal-vs-Obese |
1.935520E-03 |
| Normal-vs-Extreme_Obese |
3.626200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.610200E-01 |
| Normal_Weight-vs-Obese |
4.157600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.165000E-01 |
| Extreme_Weight-vs-Obese |
5.565400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.357800E-01 |
| Obese-vs-Extreme_Obese |
8.253800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.798500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.38220000003952E-06 |
| Normal-vs-Age(61-80Yrs) |
4.738200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.498200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.750400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.131400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.920400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.224300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.643900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.512790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.10429999997408E-06 |
| Normal-VS-Type2 PRCC |
3.685700E-02 |
| Normal-VS-KIRP CIMP |
1.765210E-01 |
| Normal-VS-Unclassified PRCC |
3.077700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.709800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.719000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.572800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.577600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.401360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.571200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.396020E-01 |
| Normal-vs-N1 |
1.836640E-01 |
| Normal-vs-N2 |
4.357200E-01 |
| N0-vs-N1 |
5.989000E-01 |
| N0-vs-N2 |
4.367000E-01 |
| N1-vs-N2 |
7.117600E-01 |
|
|
